Trial Profile
A Phase III Study Comparing Low Dose Cyclosporine, Methotrexate And Prednisone Versus Standard Dose Cyclosporine and Methotrexate As Graft Versus Host Disease Prophylaxis In Myeloablative Allogeneic Stem Cell Transplantation (ALLG BM10 trial) in patients with haematological malignancies
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 22 Jun 2021
Price :
$35
*
At a glance
- Drugs Prednisone (Primary) ; Ciclosporin; Ciclosporin
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 18 Jun 2021 Status changed from completed to withdrawn prior to enrolment.
- 08 Jun 2016 Status changed from not yet recruiting to completed.
- 14 May 2009 New trial record